bioAffinity Technologies Inc (BIAF) Financials

$15.27

$2.49 (19.48%)

As on 04-Sep-2026 16:29EDT

Market cap

$3 Mln

Revenue (TTM)

$6 Mln

P/E Ratio

--

P/B Ratio

0.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	5.90	6.16	9.36	2.53	0.00	0.00
Cost of Revenue	8.24	4.73	5.98	1.74	0.00	0.00
Gross Profit	-2.33	1.43	3.38	0.79	0.00	0.00
Operating Expenses	14.89	12.00	12.33	8.77	4.02	2.20
Operating Profit (EBIT)	-12.38	-10.57	-8.95	-7.97	-4.01	-2.21
Other Income	--	--	--	--	--	--
Profit before Tax	-15.18	-14.87	-9.03	-7.92	-8.15	-6.32
Provision for Tax	0.01	0.04	0.01	0.02	0.00	0.00
Profit after Tax (Net Income)	-15.19	-14.91	-9.04	-7.94	-8.15	-6.33
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	-6.33

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	3.77	7.28	2.60	4.86	11.04	-15.79
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	1.17	0.78	0.81	1.12	0.60	4.20
Current Liabilities	2.68	2.91	3.10	2.25	1.14	13.04
Total Liabilities	10.30	10.96	6.51	8.22	12.18	1.45

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	3.75	3.40	3.82	4.25	0.22	0.02
Current Assets	3.87	7.57	2.70	3.97	11.96	1.44
Total Assets	11.48	10.96	6.51	8.22	12.18	1.45
Total Debt*	1.44	1.16	1.50	1.58	0.25	11.36
Net Current Assets	--	4.66	-0.41	1.72	10.82	-11.59

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-9.33	-7.26	-6.04	-4.07	-2.05
Cash Flow from Investing Activities	--	-0.06	-0.08	-2.21	-0.22	--
Cash from Financing Activities	--	14.73	5.63	-0.34	14.34	3.33
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-120.17	-129.99	-21.88	-0.84	-29.18	-69.60
Cash EPS ($)	--	-125.59	-20.42	-0.83	-29.15	-69.54
Adjusted Book Value ($)	--	63.45	6.30	0.52	39.53	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-81.33	-17.59	-0.64	-14.57	-22.54
Free Cash Flow per Share ($)	--	-81.86	-17.78	-0.65	-15.36	-22.54

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-237.76	-171.58	-89.54	-237.42	133.29
ROE (%)	-274.93	-301.83	-242.45	-99.84	343.53	41.00
ROA (%)	-161.34	-170.65	-122.70	-77.80	-119.60	-791.34
EBIT Margin (%)	-256.47	-240.53	-95.45	-311.16	-116,989.67	-407,550.46
Net Margin (%)	-257.33	-241.96	-96.56	-313.47	-169,771.25	-484,411.41
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-23.17	-0.34	2.70	526.17	2.68	--
EBIT Growth (%)	-30.74	-65.87	-13.42	-40.21	-5.57	22.68
Net Profit Growth (%)	-29.91	-64.93	-13.90	2.66	-28.89	12.96
EPS Growth (%)	-446.06	-4.94	-24.90	0.97	0.58	0.15
Book Value Growth (%)	505.37	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.01	-0.04	-1.74	-0.05	--
Price / Book Value	0.80	0.02	0.14	2.85	0.04	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.21	0.36	-0.09	-1.65	1.91	--
Close Price ($)	12.18	17.70	409.50	661.73	720.00	--
High Price ($)	202.50	697.95	1,629.00	1,795.50	6,997.50	--
Low Price ($)	10.40	16.65	373.73	429.66	589.50	--
Market Cap ($ Cr)	2.88	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.16	0.58	0.33	0.02	-0.72
Short term debt to equity ratio	0.07	0.05	0.27	0.09	0.02	-0.71
Current Ratio	1.44	2.60	0.87	1.77	10.50	0.11
Quick Ratio	1.41	2.58	0.86	1.76	10.50	0.10
Interest Coverage	-337.53	-334.02	-96.63	-212.22	-2.22	-5.31

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	15.16	8.80	12.17	32.06	218.38	117.15
Asset Turnover	0.63	0.71	1.27	0.25	0.00	0.00
Receivable days	--	49.83	38.06	59.30	457.00	427.90
Inventory Days	--	3.13	1.41	2.52	30,262.57	3,798.77
Payable days	--	67.51	48.60	99.63	225,035.06	15,991.31
Cash Conversion Cycle	--	-14.56	-9.13	-37.81	-194,315.50	-11,764.64

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.